Hematopoietic stem cell mobilization with the reversible CXCR4 receptor inhibitor plerixafor (AMD3100) - Polish compassionate use experience

Annals of Hematology

Volumn 90, Issue 5, 2011, Pages 557-568

  Basak, Grzegorz Wladyslaw ^a   Knopinska Posluszny, Wanda ^b   Matuszak, Magdalena ^c   Kisiel, Elzbieta ^d   Hawrylecka, Dorota ^e   Szmigielska Kaplon, Anna ^f   Urbaniak Kujda, Donata ^g   Dybko, Jaroslaw ^g   Zielinska, Patrycja ^h   Dabrowska Iwanicka, Anna ⁱ   Werkun, Joanna ^j   Rzepecki, Piotr ^k   Wroblewska, Wiktoria ^l   Wiktor Jedrzejczak, Wieslaw ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

^c POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^d INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

^e JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^f MEDICAL UNIVERSITY OF LODZ   (Poland)

^g WROCLAW MEDICAL UNIVERSITY   (Poland)

^h MEDICAL UNIVERSITY OF SILESIA   (Poland)

ⁱ INSTITUTE OF ONCOLOGY   (Poland)

^j Lower Silesian Centre for Cellular Transplantation   (Poland)

^k MILITARY INSTITUTE OF MEDICINE   (Poland)

^l WARSAW SCHOOL OF ECONOMICS   (Poland)

more..

Author keywords

AMD3100; Mobilization; Plerixafor; Stem cells; Transplantation

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CARMUSTINE; CD34 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; MELPHALAN; METHYLPREDNISOLONE; PLERIXAFOR; PREDNISONE; PROCARBAZINE; RITUXIMAB; VINCRISTINE;

ADULT; AGED; APHERESIS; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER RADIOTHERAPY; CD34 SELECTION; CELL COUNT; COHORT ANALYSIS; COMPASSIONATE USE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; EVENING DOSAGE; FEMALE; GRAFT FAILURE; GRAFT REJECTION; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; MULTIPLE MYELOMA; NEUTROPHIL COUNT; NONHODGKIN LYMPHOMA; PREDICTION; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; RETROSPECTIVE STUDY; STEM CELL MOBILIZATION; THROMBOCYTE COUNT; TREATMENT FAILURE; WHOLE BODY RADIATION;

ADULT; AGED; ANTIGENS, CD34; COHORT STUDIES; COMPASSIONATE USE TRIALS; FEMALE; GRAFT SURVIVAL; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HETEROCYCLIC COMPOUNDS; HODGKIN DISEASE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MULTIPLE MYELOMA; POLAND; RECEPTORS, CXCR4; RETROSPECTIVE STUDIES; TRANSPLANTATION, AUTOLOGOUS; YOUNG ADULT;

EID: 79956133361     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-010-1098-7     Document Type: Article

References (28)

1. Harousseau JL (2009) Hematopoietic stem cell transplantation in multiple myeloma. J Natl Compr Canc Netw 7(9):961-970
2. Moskowitz AJ, Moskowitz CH (2009) Controversies in the treatment of lymphoma with autologous transplantation. Oncologist 14(9):921-929. doi:10.1634/theoncologist.2009-0162
3. Gratwohl A, Baldomero H, Schmid O, Horisberger B, Bargetzi M, Urbano-Ispizua A (2005) Change in stem cell source for hematopoietic stem cell transplantation (hsct) in europe: a report of the ebmt activity survey 2003. Bone Marrow Transplant 36 (7):575-590. doi:10.1038/sj.bmt.1705104
4. Bender JG, To LB, Williams S, Schwartzberg LS (1992) Defining a therapeutic dose of peripheral blood stem cells. J Hematother 1 (4):329-341
5. Montgomery M, Cottler-Fox M (2007) Mobilization and collection of autologous hematopoietic progenitor/stem cells. Clin Adv Hematol Oncol 5(2):127-136 (Pubitemid 46455272)
6. Bensinger W, DiPersio JF, McCarty JM (2009) Improving stem cell mobilization strategies: future directions. Bone Marrow Transplant 43(3):181-195. doi:10.1038/bmt.2008.410
7. Kucia M, Jankowski K, Reca R, Wysoczynski M, Bandura L, Allendorf DJ, Zhang J, Ratajczak J, Ratajczak MZ (2004) Cxcr4- sdf-1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol 35(3):233-245
8. Villalon L, Odriozola J, Larana JG, Zamora C, Perez de Oteyza J, Jodra MH, Lopez J, Herrera P, Roldan E, Ramos ML, Ramos P, Navarro JL (2000) Autologous peripheral blood progenitor cell transplantation with <2x10(6) cd34(+)/kg: an analysis of variables concerning mobilisation and engraftment. Hematol J 1(6):374-381. doi:10.1038/sj/thj/6200057
9. Pusic I, Jiang SY, Landua S, Uy GL, Rettig MP, Cashen AF, Westervelt P, Vij R, Abboud CN, Stockerl-Goldstein KE, Sempek DS, Smith AL, DiPersio JF (2008) Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation. Biol Blood Marrow Transplant 14 (9):1045-1056. doi:10.1016/j.bbmt.2008.07.004
10. DiPersio JF, Stadtmauer EA, Nademanee A, Micallef IN, Stiff PJ, Kaufman JL, Maziarz RT, Hosing C, Fruehauf S, Horwitz M, Cooper D, Bridger G, Calandra G (2009) Plerixafor and g-csf versus placebo and g-csf to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma. Blood 113(23):5720-5726. doi:10.1182/blood-2008-08-174946
11. DiPersio JF, Micallef IN, Stiff PJ, Bolwell BJ, Maziarz RT, Jacobsen E, Nademanee A, McCarty J, Bridger G, Calandra G (2009) Phase iii prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-hodgkin's lymphoma. J Clin Oncol 27 (28):4767-4773. doi:10.1200/JCO.2008.20.7209
12. Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, Coiffier B, Fisher RI, Hagenbeek A, Zucca E, Rosen ST, Stroobants S, Lister TA, Hoppe RT, Dreyling M, Tobinai K, Vose JM, Connors JM, Federico M, Diehl V (2007) Revised response criteria for malignant lymphoma. J Clin Oncol 25 (5):579-586. doi:10.1200/JCO.2006.09.2403 (Pubitemid 350002966)
13. Durie BG, Harousseau JL, Miguel JS, Blade J, Barlogie B, Anderson K, Gertz M, Dimopoulos M, Westin J, Sonneveld P, Ludwig H, Gahrton G, Beksac M, Crowley J, Belch A, Boccadaro M, Cavo M, Turesson I, Joshua D, Vesole D, Kyle R, Alexanian R, Tricot G, Attal M, Merlini G, Powles R, Richardson P, Shimizu K, Tosi P, Morgan G, Rajkumar SV (2006) International uniform response criteria for multiple myeloma. Leukemia 20(9):1467-1473. doi:10.1038/sj.leu.2404284 (Pubitemid 44264086)
14. Calandra G, McCarty J, McGuirk J, Tricot G, Crocker SA, Badel K, Grove B, Dye A, Bridger G (2008) Amd3100 plus g-csf can successfully mobilize cd34+ cells from non-hodgkin's lymphoma, hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use data. Bone Marrow Transplant 41(4):331-338. doi:10.1038/sj.bmt.1705908 (Pubitemid 351330727)
15. Tricot G, Cottler-Fox MH, Calandra G (2010) Safety and efficacy assessment of plerixafor in patients with multiple myeloma proven or predicted to be poor mobilizers, including assessment of tumor cell mobilization. Bone Marrow Transplant 45(1):63-68. doi:10.1038/bmt.2009.130
16. Fowler CJ, Dunn A, Hayes-Lattin B, Hansen K, Hansen L, Lanier K, Nelson V, Kovacsovics T, Leis J, Calandra G, Maziarz RT (2009) Rescue from failed growth factor and/or chemotherapy hsc mobilization with g-csf and plerixafor (amd3100): an institutional experience. Bone Marrow Transplant 43(12):909-917. doi:10.1038/bmt.2008.409
17. Stiff P, Micallef I, McCarthy P, Magalhaes-Silverman M, Weisdorf D, Territo M, Badel K, Calandra G (2009) Treatment with plerixafor in non-hodgkin's lymphoma and multiple myeloma patients to increase the number of peripheral blood stem cells when given a mobilizing regimen of g-csf: implications for the heavily pretreated patient. Biol Blood Marrow Transplant 15 (2):249-256. doi:10.1016/j.bbmt.2008.11.028
18. Fruehauf S, Ehninger G, Hubel K, Topaly J, Goldschmidt H, Ho AD, Muller S, Moos M, Badel K, Calandra G (2010) Mobilization of peripheral blood stem cells for autologous transplant in nonhodgkin's lymphoma and multiple myeloma patients by plerixafor and g-csf and detection of tumor cell mobilization by pcr in multiple myeloma patients. Bone Marrow Transplant 45(2):269-275. doi:10.1038/bmt.2009.142
19. Hubel K, Fresen M, Lange F, Salwender H, Basara N, Bogner C, Galm O, Hartwig R, Dressler S, Ebinger M, Frickhofen N, Hertenstein B, Kiehl M, Liebler S, Von Lilienfeld-Toal M, Weidmann E, Weigelt C, Kroner N (2010) Plerixafor for stem cell mobilization in poor mobilizers: results from the german compassionate use programme. Bone Marrow Transplant 45 (Supplement 2):S316
20. Worel N, Rosskopf K, Nachbaur D, Kasparu H, Russ G, Namberger K, Leitner G, Kalhs P, Schogl E, Witt V, Greinix H, Keil F, Linkesch W (2010) Plerixafor plus g-csf can successfully mobilize cd34+ cells from patients who have previously failed chemotherapy and/or cytokine mobilization: the compassionate use experience in austria. Bone Marrow Transplant 45 (Supplement 2):S318
21. Mohty M, Lefrere F, Caillot D, Azar N, Miclea JM, Broussais F, Marolleau JP, Attal M, Milpied N, Gisselbracht C, Moreau P, Chabannon C (2010) Plerixafor plus g-csf can mobilize autologous haematopoietic stem cells from heavily pre-treated patients failing previous mobilization attempts: analysis of the french compassionate use programme. Bone Marrow Transplant 45 (Supplement 2):S319
22. Koristek Z, Folber F, Lysak D, Pohlreich D, Lanska M, Rusinakova Z, Papajik T, Kepak T, Novak J, Mayer J, Erba J (2010) The use of plerixafor in czech transplant centers. Bone Marrow Transplant 45(Supplement 2):S320
23. Jaksic O, Basic-Kinda S, Maricic I, Bojanic I, Nemet B, Pejsa V, Labar B (2010) Effective stem cell mobilization with plerixafor + g-csf followed by large-volume leukapheresis in poor mobilizers: the experience of the croatian cooperative group for hematologic diseases (krohem). BoneMarrowTransplant 45(Supplement 2):S321
24. Basak GW, Urbanowska E, Witkowska M, Zdunczyk D, Waszczuk-Gajda A, Skwierawska K, Drozd J, Skibinska M, Glazer M, Madry K, Halaburda K, Torosian T, Krol M, Wiktor-Jedrzejczak W (2010) Stem cell mobilization with plerixafor in poorly mobilizing myeloma and lymphoma patients - a single centre experience and strategies. Bone Marrow Transplantation 45 (Supplement 2):S320
25. Bensinger W, Appelbaum F, Rowley S, Storb R, Sanders J, Lilleby K, Gooley T, Demirer T, Schiffman K, Weaver C et al (1995) Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 13 (10):2547-2555
26. Ketterer N, Salles G, Moullet I, Dumontet C, ElJaafari-Corbin A, Tremisi P, Thieblemont C, Durand B, Neidhardt-Berard EM, Samaha H, Rigal D, Coiffier B (1998) Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignancies. Br J Haematol 103(1):235-242 (Pubitemid 28470825)
27. Reca R, Cramer D, Yan J, Laughlin MJ, Janowska-Wieczorek A, Ratajczak J, Ratajczak MZ (2007) A novel role of complement in mobilization: immunodeficient mice are poor granulocyte-colony stimulating factor mobilizers because they lack complementactivating immunoglobulins. Stem Cells 25(12):3093-3100. doi:10.1634/stemcells.2007-0525 (Pubitemid 350294435)
28. PA BEA, Winters JL (2003) Effects of high whole blood flow rates and high peripheral blood cell counts on cd34+ cell yield and cross-cellular contamination. Cytotherapy 5:446